Timmerman Report is an independent biotech publication. Subscribe today! https://xitter.cf/t.co/0HEk9RIEKV…
Seattle
Joined January 2015
- Tweets1.3K
- Following4
- Followers8.2K
- Likes578
Creating PROTACs and RIPTACs as part of a new class of medicines: Listen to Tim Shannon @canaanpartners, a former exec of @ArvinasInc and Halda Therapeutics, on The Long Run. Sponsors: @AlphaSenseInc & Dash Bio. timmermanreport.com/2026/10/…
Touch, Pain & The Edge of Neuroscience. Ardem Patapoutian of @scrippsresearch is the latest guest on The Long Run. Sponsors: @AlphaSenseInc & Dash Bio. timmermanreport.com/2026/10/…
Long-lasting antibodies for immune disorders. Cameron Turtle of Spyre Therapeutics is the latest guest on The Long Run. Sponsors: @AlphaSenseInc and Dash Bio. timmermanreport.com/2026/09/…
Drugs That Go Where None Could Before. Mathai Mammen of Parabilis Medicines is the latest guest on The Long Run. Sponsors: @AlphaSenseInc & Dash Bio. timmermanreport.com/2026/09/…
A vaccine for Epstein-Barr Virus. Gary Nabel, CEO of ModeX Therapeutics, is the latest guest on The Long Run podcast. Sponsors: @AlphaSenseInc & Dash Bio. timmermanreport.com/2026/08/…
9 Young Scientists to Watch. timmermanreport.com/2026/08/…
Genetic Medicines for Kidney Diseases. Listen to Jason Coloma, CEO of South San Francisco-based Maze Therapeutics, on The Long Run. Sponsors: @AlphaSenseInc & Dash Bio. timmermanreport.com/2026/08/…
Takeda's 1st-in-class orexin approval, Eli Lilly's Obesity Money Gusher, & Three More IPOs. Get that and more in the weekly Frontpoints. (Sub. req.) timmermanreport.com/2026/08/…
LifeMine, in Greg Verdine's Big Year, Raises $263M for Safer Drug for Organ Transplants. timmermanreport.com/2026/08/…
Inhalable medicines for severe lung diseases. Listen to Lyn Baranowski, CEO of Boston-based Avalyn Pharma, on The Long Run. Sponsors: @AlphaSenseInc and Dash Bio. timmermanreport.com/2026/07/…
Enjoyed this conversation with John Flavin of Portal Innovations about my circuitous path in biotech journalism. labratstounicorns.com/listen…
A Schizophrenia Drug Patients Can Stick With. Heather Turner of LB Pharmaceuticals is the latest guest on The Long Run. Sponsors: @AlphaSenseInc and Dash Bio. timmermanreport.com/2026/07/…
Precision Cancer Drugs & Combos. Listen to Troy Wilson, CEO of San Diego-based Kura Oncology, on the latest episode of The Long Run. Sponsors: @AlphaSenseInc and Dash Bio. timmermanreport.com/2026/06/…
Austin, Tex.-based Ollin Biosciences Advances with $330M to Challenge Roche in DME and Wet AMD. timmermanreport.com/2026/06/…
Small molecules to correct disease. Listen to @srikosuri on The Long Run. Sponsored by @AlphaSenseInc and Dash Bio. timmermanreport.com/2026/06/…
RevMed's Moment in the Sun, In Vivo CAR-T's Shine & NewLimit's Healthspan Haul. Catch up on a busy week in Frontpoints. timmermanreport.com/2026/06/…
Beyond Language: Why Drug Discovery Needs a Different Kind of AI. Guest editorial by Woody Sherman of PsiThera. timmermanreport.com/2026/06/…
Reimagining Science for the AI Era. Listen to @beckypferdehirt CEO of Radial @AsteraInstitute discuss the $500M nonprofit seeking to create better conditions for AI in biology. Sponsors: @AlphaSenseInc Dash Bio. timmermanreport.com/2026/06/…
Biotech in the Balance: Saving a Strategic Industry in an Age of Public Distrust. Listen to @jmaxlevin discuss his new book on The Long Run. Sponsored by: @AlphaSenseInc & Dash Bio. timmermanreport.com/2026/05/…
UCB Takes Over Candid, Odyssey's IPO & Makary's Rough Week.
timmermanreport.com/2026/05/…